Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith
NEW YORK — Kimberly-Clark’s nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world’s biggest consumer market, the United States, will keep growing even as lower-income shoppers trim their budgets, according to analysts. The cash-and-stock deal, announced earlier on Monday, is set to close late...